An observational study in Neurocysticercosis and HIV/AIDS, sponsored by Technical University of Munich. Completed at 1 site in Tanzania. Open to participants aged 14 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-29.
Sponsored by Technical University of Munich · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aims to compare the burden of neurocysticercosis among people living with HIV to people not infected with HIV.
People living with HIV and matched HIV negative controls will be tested serologically for cysticercosis, examined neurologically and will undergo CT scanning to determine the prevalence and presentation of NCC.
Furthermore, the immune system response in HIV patients with Taenia solium neurocysticercosis will be assessed.
21 studies on the registry are indexed under Neurocysticercosis; 5 are open to participants now.
Browse Neurocysticercosis studies →Technical University of Munich is the lead sponsor of 322 studies on the registry; 60 are open to participants now.
Counted across the registry records on this site, refreshed daily.
1000 patients from HIV clinics will be recruited at the study sites in Mbeya and Iringa region. For each HIV-positive patient an HIV-negative control matched by age, sex and location will be included.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
People living with HIV (ART naive or on ART)
Diagnostic Test: Diagnosis of (Neuro)cysticercosis
HIV-negative people. Each participant is matched for age, sex and location to a study participant living with HIV
Diagnostic Test: Diagnosis of (Neuro)cysticercosis
* Serological tests for cysticercosis * Neurological examination and cerebral CT scan for the diagnosis of neurocysticercosis * Stool testing for T. solium
Prevalence of cysticercosis
Prevalence of cysticercosis among people living with HIV and matched HIV-negative individuals in rural Tanzania where pig farming is common
Time frame: Single assessment at inclusion into study (serological testing)
Prevalence of neurocysticercosis
Prevalence of neurocysticercosis among people living with HIV and matched HIV-negative individuals in rural Tanzania where pig farming is common
Time frame: Single assessment through cerebral CT scan at inclusion into study
Th1 cytokines among neurocysticercosis patients
To compare the specific peripheral immune response against T. solium neurocysticercosis between symptomatic and asymptomatic patients measured by concentration of Th1 cytokines.
Time frame: One time assessment through immunological testing at inclusion into study
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Apr 2018 to primary completion in Apr 2021, 36 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Technical University of Munich →